BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET

  October 17, 2024

   · 

  1 min read
• Press Releases

  IgGenix Announces First Patient Dosed in Phase 1 Clinical Trial “ACCELERATE Peanut” Evaluating IGNX001 in Peanut Allergy

  October 17, 2024

   · 

  3 min read
• Press Releases

  Latigo Biotherapeutics Doses First Participant in Phase 1 Clinical Trial of LTG-305 for Non-Opioid Treatment of Pain

  October 17, 2024

   · 

  3 min read
• Press Releases

  Sunbird Bio Raises Additional $14 Million to Advance Broadest Blood-Based Diagnostic Platform in Alzheimer’s Disease and Other Neurological Disorders

  October 17, 2024

   · 

  4 min read
• Press Releases

  Renovaro Announces Strategic Restructuring and Leadership Transition

  October 17, 2024

   · 

  5 min read
• Press Releases

  Biomerica Reports First Quarter Fiscal 2025 Financial Results

  October 17, 2024

   · 

  6 min read
• Press Releases

  Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access

  October 17, 2024

   · 

  4 min read
• Press Releases

  Adimab Announces Hire of Aaron Sato as Chief Strategy Officer

  October 17, 2024

   · 

  3 min read
• Press Releases

  Lilly confirms date and conference call for third-quarter 2024 financial results announcement

  October 17, 2024

   · 

  1 min read
• Press Releases

  Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models

  October 17, 2024

   · 

  4 min read